Cardiovascular disease outcomes among established cigar users 40 years and older: Findings from the population assessment of tobacco and health (PATH) study, waves 1–5 (2013–2019)

Eva Sharma; Zhiqun Tang; Kristin Lauten; Marushka L. Silveira; Cristine D. Delnevo; Kathryn C. Edwards; Daniela Marshall; Diann E. Gaalema; Izabella Zandberg; Bria Graham-Glover; Derick L. Rivers; Omoye E. Imoisili; Kirstie Neal; Raymond Niaura; Maansi Bansal-Travers; Andrew Hyland; K. Michael Cummings

Preventive Medicine Reports (Jan 2024)

Cardiovascular disease outcomes among established cigar users 40 years and older: Findings from the population assessment of tobacco and health (PATH) study, waves 1–5 (2013–2019)

Eva Sharma,
Zhiqun Tang,
Kristin Lauten,
Marushka L. Silveira,
Cristine D. Delnevo,
Kathryn C. Edwards,
Daniela Marshall,
Diann E. Gaalema,
Izabella Zandberg,
Bria Graham-Glover,
Derick L. Rivers,
Omoye E. Imoisili,
Kirstie Neal,
Raymond Niaura,
Maansi Bansal-Travers,
Andrew Hyland,
K. Michael Cummings

Affiliations

Eva Sharma: Westat, Rockville, MD, USA; Corresponding author at: 1600 Research Blvd, Rockville, MD 20850, USA.
Zhiqun Tang: Westat, Rockville, MD, USA
Kristin Lauten: Westat, Rockville, MD, USA
Marushka L. Silveira: National Institute of Dental and Craniofacial Research, National Institutes of Health, Bethesda, MD, USA; Kelly Government Solutions, Rockville, MD, USA
Cristine D. Delnevo: Rutgers Center for Tobacco Studies, Rutgers Biomedical and Health Sciences, Rutgers University, New Brunswick, NJ, USA
Kathryn C. Edwards: Westat, Rockville, MD, USA
Daniela Marshall: National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, USA; Axle Informatics, Rockville, MD, USA
Diann E. Gaalema: Department of Psychiatry, University of Vermont, Burlington, VT, USA
Izabella Zandberg: Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA
Bria Graham-Glover: Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA
Derick L. Rivers: Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA
Omoye E. Imoisili: Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA
Kirstie Neal: Center for Tobacco Products, Food and Drug Administration, Silver Spring, MD, USA
Raymond Niaura: Department of Social and Behavioral Sciences, NYU College of Global Public Health, New York University, NY, USA
Maansi Bansal-Travers: Department of Health Behavior, Division of Cancer Prevention & Population Sciences, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
Andrew Hyland: Department of Health Behavior, Division of Cancer Prevention & Population Sciences, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA
K. Michael Cummings: Department of Psychiatry and Behavioral Sciences, Medical University of South Carolina, Charleston, SC, USA

Journal volume & issue: Vol. 37
p. 102569

Abstract

Read online

This study examined associations between established cigar use and prevalence and incidence of cardiovascular diseases (CVD; congestive heart failure, stroke, or heart attack/needed bypass surgery) among U.S. adults, 40 years or older. Using Waves 1–5 (2013–2019) of the Population Assessment of Tobacco and Health (PATH) Study, incidence (Nindividuals (Nind) = 6,692; Nobservations (Nobs) = 23,738) and prevalence (Nind = 7,819; Nobs = 33,952) of CVD outcomes were examined using weighted generalized estimating equations (WGEEs) among adults who were exclusive current/former established cigar smokers (ever cigar smokers who have smoked fairly regularly), exclusive current/former established cigarette smokers (lifetime smokers of 100 or more cigarettes), dual current/former established cigarette and cigar smokers compared with never smokers of cigars or cigarettes, adjusting for covariates. The population-averaged incidence of CVD from one wave to next among exclusive current/former established cigar smokers during a six-year period based on WGEEs was low (overall average rate of 3.0 %; 95 % CI: 1.2, 7.0). Compared with never users, exclusive current/former established cigar smokers (OR = 1.67, 95 % CI: 1.11, 2.51) and exclusive current/former established cigarette smokers (OR = 2.12, 95 % CI: 1.45, 3.09) were more likely to have any CVD outcome in unadjusted analyses. When adjusted for covariates, only exclusive current/former established cigarette use was associated with CVD outcomes (AOR = 1.60, CI: 1.07, 2.40). Results suggest that exclusive established use of cigars or duration of exclusive cigar use was not associated with lifetime CVD prevalence compared with never cigar or cigarette smokers, which is important in understanding health outcomes in cigar users.

Published in Preventive Medicine Reports

ISSN: 2211-3355 (Online)
Publisher: Elsevier
Country of publisher: United States
LCC subjects: Medicine
Website: http://www.journals.elsevier.com/preventive-medicine-reports/

About the journal

Abstract

Keywords